Northwest Biotherapeutics NWBO
OTC NWBO
$0.15 +0.00 (+0.00%)
At close: Oct 2, 2026 · 4:00 PM EDT

Northwest Biotherapeutics (NWBO) Depreciation and Depletion (2014 - 2026)

Updated

Northwest Biotherapeutics (NWBO) reported Depreciation and Depletion of $500,000 for Q2 2026, unchanged from $500,000 a year earlier and down 16.7% from the prior quarter.

Analysis

Northwest Biotherapeutics (NWBO) Depreciation and Depletion (2014 - 2026) Analysis & Trends

Over the twelve months ended Jun 30, 2026, Northwest Biotherapeutics' Depreciation and Depletion came in at $2 million, up 11.1% year-over-year; for FY2025, it was $1.9 million, up 11.8% from FY2024.

  • Depreciation and Depletion has increased for six consecutive years, with a five-year compound annual growth rate of 85.3% (FY2020 to FY2025).
  • By year, Depreciation and Depletion came in at $1.7 million in FY2024 (+13.3%), $1.5 million in FY2023 (+15.4%), $1.3 million in FY2022 (+333.3%) and $300,000 in FY2021 (+244.8%).
  • Five-year quarterly Depreciation and Depletion spans a low of $100,000 in Q1 2022 and a high of $600,000 in Q1 2026.
  • Year over year, Depreciation and Depletion gained in 1 of the last four quarters, with growth averaging 12.5%.
  • The high point for year-over-year Depreciation and Depletion in five years was Q1 2023 (growth of 200.0%); the low point was Q2 2023 (a decline of 20.0%).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Dep. & Depletion (Qtr)
1 Eli Lilly 1,076.25 Bn 1,044.84 Bn 19.71 Bn -
2 Johnson & Johnson 617.18 Bn 535.70 Bn 17.26 Bn -
3 AbbVie 464.58 Bn 437.73 Bn 12.70 Bn 194.00 Mn
4 Merck 356.04 Bn 310.47 Bn 12.21 Bn 599.00 Mn
5 Novartis Ag 269.07 Bn 224.94 Bn 11.24 Bn -
6 Astrazeneca 243.21 Bn 216.77 Bn 12.86 Bn -
7 Amgen 217.88 Bn 173.28 Bn 7.24 Bn -
8 Gilead Sciences 179.62 Bn 153.74 Bn 6.22 Bn 98.00 Mn
9 Pfizer 158.45 Bn 105.40 Bn 10.94 Bn -
10 Northwest Biotherapeutics 250.40 Mn 240.41 Mn - 500,000.00
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 500,000.00
Mar 31, 2026 600,000.00
Jun 30, 2025 500,000.00
Mar 31, 2025 400,000.00
Jun 30, 2024 500,000.00
Mar 31, 2024 400,000.00
Dec 31, 2023 400,000.00
Sep 30, 2023 400,000.00
Jun 30, 2023 400,000.00
Mar 31, 2023 300,000.00
Dec 31, 2022 400,000.00
Sep 30, 2022 300,000.00
Jun 30, 2022 500,000.00
Mar 31, 2022 100,000.00
Dec 31, 2020 54,000.00
Sep 30, 2020 17,000.00
Jun 30, 2020 2,000.00
Mar 31, 2020 14,000.00
Dec 31, 2019 5,000.00
Sep 30, 2019 8,000.00
API Access

Northwest Biotherapeutics Depreciation and Depletion API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=depreciation-and-depletion&ticker=NWBO&period=max&api_key=YOUR_API_KEY